期刊文献+

血栓抽吸导管联合替罗非班在老年急性ST段抬高性心肌梗死患者的临床研究 被引量:6

Efficacy of thrombus aspiration catheter combined with triofiban in therapy on elderly patients with acute ST-segment elevation myocardial infarction
下载PDF
导出
摘要 目的探讨血栓抽吸导管联合替罗非班治疗老年急性ST性段抬高型心肌梗死患者的临床疗效。方法选择2011年2月-2012年6月我院行急诊经皮冠状动脉介入(PCI)治疗的老年(年龄〉65岁)急性ST段抬高性心肌梗死患者60例,经冠状动脉造影证实为有血栓负荷,随机分为应用替罗非班联合血栓抽吸导管治疗为治疗组(30例),同期应用替罗非班未联合血栓抽吸导管治疗为对照组(30例)。比较两组术后患者的心肌梗死血管血流变化(TIMI分级)、术后心肌灌注分级(TMPG)、术后ST段回落程度、出血性并发症和住院期间不良事件(MACE)的发生率。结果治疗组患者即刻(TIMI)血流、术后心肌灌注分级(TMPG)、术后ST段回落程度、住院期间不良事件(MACE)的发生率明显优于对照组,致命性出血两组无统计学差异。结论血栓抽吸导管联合替罗非班在老年急性ST段抬高性心肌梗死患者应用安全和有效。 Objective To research the effect of thrombus aspiration Catheter combined with Triofiban therapy on elderly patients with Acute ST-segment elevation Myocardial Infarction. Methods From Feb 2011 to Jun 2012 sixty aged patients more than 65 with STMI and thrombotic burden lesion confirmed by coronary angiography who underwent primary perculaneous coronary artery(PCI) treatment were enrolled in the study.The patients were divided into two groups at random;The treatment group received Catheter combined with Triofiban,The control group had no receiving Catheter combined with Triofiban.Then the differences of thrombolysis in myo-cardial infarction(TIMI) Flow grade,TIMI myocardial perfusion grade(TMPG)and major adverse cardiac events (MACE)in hospital and MACE were compared between two groups. Results The number of patients with three graded TIMI flow and TMPG after the therapy in the treatment group less than control group,MACE incidencein hospital and MACE in 12 months and fatal hemorrhagic complications have no significantly differences in two groups. Conclusion Application of thrombus Aspiration Catheter combined with Triofiban therapy on elderly Patients with Acute Myocardial Infarction was effective and safely.
作者 尤家聪 孙彤
出处 《中国医药科学》 2014年第6期12-16,共5页 China Medicine And Pharmacy
关键词 急性心肌梗死 替罗非班 血栓抽吸导管 老年 Acute myocardial infarction Thrombus aspiration catheter Triofiban Elderly
  • 相关文献

参考文献7

二级参考文献38

  • 1王美玲.氯吡格雷联合曲美他嗪治疗急性心肌梗死的临床探讨[J].心血管康复医学杂志,2005,14(3):257-258. 被引量:15
  • 2颜红兵,朱小玲,高海,李南,李世英,艾辉,王健,柯元南.直接冠状动脉介入治疗时无复流高危患者是否应用Guardwire Plus装置的对比研究[J].中国介入心脏病学杂志,2005,13(3):138-141. 被引量:11
  • 3任宏生,朱兴雷.氯吡格雷防治动脉粥样硬化缺血性疾病的研究进展[J].心血管病学进展,2006,27(3):274-281. 被引量:29
  • 4KEELEY E C, BOURA J A, GRINES C L. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative of 23 randomised trials[J]. Lancet, 2003,361 : 13- 20.
  • 5MORISHA I, SONE T, OKUMURA K, et al. Angiographic no-reflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction[J]. J Am Coll Cardiol, 2000,36 : 1202- 1209.
  • 6REZKALLA S H, KLONER R A. No-reflow phenomenon[J]. Circulation, 2002,105: 656- 662.
  • 7ROMANO M, BUFFOLI F, TOMASI L, et al. The no-flow phenomenon in acute myocardial infarction after primary angioplasty: incidence, predictive factors, and long-term outcome[J]. J Cardiovasc Med, 2008, 9:59 63.
  • 8BROSH D, ASSALIA R, MAGER A, et al. Effect of no-flow during percutaneous coronary intervention for acute myocardial infarction on six-month mortality [J]. Am J Cardiol,2007,99:442-445.
  • 9TOPOI. E J, YADAV J S. Recognition of the importance of embolization in atherosclerotic vascular disease]J]. Circulation, 2000,101: 570- 580.
  • 10YANG Y J, ZHAO J L, YOU S J, et al. Different effect of tirofiban and aspirin plus clopidogrel on myo- cardial no-reflow in a miniswine modal of acute myo- cardial infarction and reperfusion[J]. Heart, 2006.92 : 1131-1137.

共引文献188

同被引文献68

引证文献6

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部